Pay in 4 interest-free payments of $3037.50 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
El vértigo horizontal
Así lo reconoce la Agenda 2030 para el Desarrollo Sostenible
según se establecieron en la Cumbre Mundial sobre el Desarrollo Sostenible en el 2002
de Gonzalo de Berceo
Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for Central Nervous System Disorders Jessica Taft El vértigo horizontalExamining Glucagon Like Peptide 1 Receptor (GLP 1R) Agonists for Central Nervous System Disorders Glucagon like peptide 1 receptor (GLP 1R) agonists, originally developed for type 2 diabetes patients and popularized by their ability to rapidly reduce body weight in patients with obesity, have recently received a lot of national attention. Repurposing GLP 1R agonists to treat some central nervous disorders is promising, but comparatively understudied.